|
Market Closed -
Nasdaq Stockholm
12:00:00 2026-10-23 EDT
|
5-day change | 1st Jan Change | ||
| 1.225 SEK | -40.24% |
|
-40.53% | -75.05% |
| 10-23 | Boule Diagnostics AB, Q3 2026 Earnings Call, Oct 23, 2026 | |
| 10-23 | 27 stocks have hit new 52-week lows on the Stockholm Stock Exchange so far today | FW |
Company Valuation: Boule Diagnostics AB
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 947.5 | 586.4 | 435.7 | 348.7 | 190.7 | 47.57 | - | - |
| Change | - | -38.11% | -25.7% | -19.96% | -45.32% | -75.05% | - | - |
| Enterprise Value (EV) 1 | 1,014 | 594.6 | 495.9 | 521 | 394.8 | 244.1 | 232.1 | 213.6 |
| Change | - | -41.37% | -16.6% | 5.06% | -24.23% | -38.16% | -4.93% | -7.98% |
| P/E | 41.7x | 33.6x | 17.5x | -1.56x | -49.1x | -4.87x | 5.53x | 2.79x |
| PBR | 3.2x | 1.27x | 0.92x | 1.29x | 1.14x | 0.27x | 0.26x | 0.24x |
| PEG | - | -0.5x | 0.4x | 0x | 0.5x | -0x | -0x | 0x |
| Capitalization / Revenue | 2.05x | 1.07x | 0.76x | 0.62x | 0.39x | 0.1x | 0.1x | 0.09x |
| EV / Revenue | 2.19x | 1.08x | 0.87x | 0.93x | 0.81x | 0.54x | 0.48x | 0.42x |
| EV / EBITDA | 14.9x | 10.6x | 7.76x | -2.23x | 9.77x | 9.09x | 5.14x | 3.82x |
| EV / EBIT | 28.2x | 20.5x | 12.6x | -2.02x | 19x | 30.3x | 8.98x | 5.89x |
| EV / FCF | -76.8x | -6.88x | -15.8x | -13.3x | -146x | 11.5x | 9.67x | 7.05x |
| FCF Yield | -1.3% | -14.5% | -6.31% | -7.54% | -0.68% | 8.68% | 10.3% | 14.2% |
| Dividend per Share 2 | 0.55 | - | - | - | - | - | - | 0.2 |
| Rate of return | 1.13% | - | - | - | - | - | - | 16.3% |
| EPS 2 | 1.17 | 0.45 | 0.64 | -5.75 | -0.1 | -0.2517 | 0.2214 | 0.4384 |
| Distribution rate | 47% | - | - | - | - | - | - | 45.6% |
| Net sales 1 | 463.3 | 548.1 | 571.3 | 558.5 | 489.7 | 453.1 | 483.3 | 512.6 |
| EBITDA 1 | 68.1 | 56.1 | 63.9 | -233.3 | 40.4 | 26.85 | 45.17 | 55.95 |
| EBIT 1 | 36 | 29 | 39.3 | -257.4 | 20.8 | 8.05 | 25.86 | 36.23 |
| Net income 1 | 23.3 | 12.7 | 25 | -223.3 | -3.8 | -9.773 | 8.596 | 17.03 |
| Net Debt 1 | 66.6 | 8.2 | 60.2 | 172.3 | 204.1 | 196.5 | 184.5 | 166 |
| Reference price 2 | 48.800 | 15.100 | 11.220 | 8.980 | 4.910 | 1.225 | 1.225 | 1.225 |
| Nbr of stocks (in thousands) | 19,417 | 38,833 | 38,833 | 38,833 | 38,833 | 38,833 | - | - |
| Announcement Date | 2/3/22 | 2/2/23 | 2/6/24 | 2/10/25 | 2/11/26 | - | - | - |
1SEK in Million2SEK
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -4.87x | 0.54x | 9.09x | -.--% | 4.79M | |
| 34.53x | 5.85x | 22.47x | 0.28% | 249B | |
| 36.99x | 6.96x | 21.81x | 0.63% | 162B | |
| 51.68x | 12.65x | 27.12x | -.--% | 157B | |
| 17.34x | 3.44x | 11.18x | -.--% | 66.22B | |
| 49.46x | 12.26x | 27.02x | -.--% | 52.3B | |
| 20.5x | 2.46x | 12.41x | 2.46% | 52.18B | |
| 35.31x | 7.06x | 22.39x | -.--% | 51.34B | |
| 33.72x | 6.68x | 22.73x | 0.59% | 48.79B | |
| 79.42x | 7.56x | 22.95x | -.--% | 44.57B | |
| Average | 35.41x | 6.55x | 19.92x | 0.4% | 88.35B | |
| Weighted average by Cap. | 39.06x | 7.46x | 22.04x | 0.37% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- BOUL Stock
- Valuation Boule Diagnostics AB
Select your edition
All financial news and data tailored to specific country editions
